FERTIN PHARMA A/S: Financial statements 2022
CVR: 25834844
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 892,580,000 and a net result of DKK -91,376,000 compared with DKK 37,642,000 the year before. That is a decrease of 4.3% compared with the year before. The profit margin was -10.2%. Equity in the 2022 report amounted to DKK 596,345,000. The solvency ratio was 26.5%. The company had 622 employees in the financial year.
- Revenue
- DKK 892,580,000
- Gross Profit
- DKK 25,164,000
- Profit/Loss
- DKK -91,376,000
- Equity
- DKK 596,345,000
- Total Assets
- DKK 2,249,475,000
- Employees
- 622
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 892.6M | 25.2M | -91.4M | 596.3M | 622 |
| 2021 | 932.5M | 161.4M | 37.6M | 681.4M | 569 |
| 2020 | 991.1M | 246.4M | 155.4M | 770.1M | 674 |
| 2019 | 881.6M | 190.8M | 81.3M | 778.3M | 661 |
| 2018 | 812.5M | 121.4M | 45.8M | 896M | 609 |
Official annual report
Keep an eye on FERTIN PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
FERTIN PHARMA A/S has published its annual report for 2021. Revenue came to DKK 932,545,000, and the net result was DKK 37,642,000.
As of May 27, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FERTIN PHARMA A/S.
As of May 27, 2022, EY Godkendt Revisionspartnerselskab has stepped down as auditor of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.
